Relay Therapeutics, Inc.
corporate_fare Company Profile
Relay Therapeutics, Inc. (NASDAQ:RLAY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for RLAY at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Relay Therapeutics Advances Zovegalisib Triplet to Phase 3 for Frontline Breast Cancer with Promising Clinical Data
- Relay Therapeutics' Zovegalisib Triplet Shows 44% ORR, Advances to Phase 3 in Metastatic Breast Cancer
- Shareholders to Vote on 50% Increase in Authorized Common Stock, Enabling Significant Future Capital Raises
- Relay Therapeutics Reports Strong Phase 1/2 Zovegalisib Data, Validating Phase 3 Dose in Breast Cancer
- Relay Therapeutics Extends Cash Runway into 2029, Reports Reduced Losses, and Highlights Breakthrough Therapy Designation for Lead Candidate
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$15.36M
Net Income
-$276.48M
Diluted EPS
-$1.61
Op. Cash Flow
-$235.46M
Free Cash Flow
-$235.87M
Operating Income
-$302.74M
Cash & Equivalents
$84.02M
Debt / Equity
0.00×
Net Margin
-18.01×
Shares Outstanding
173.87M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-076739
show_chartPrice Chart
Loading chart...
feed RLAY - Filings & News (Page 2)
RLAY
Apr 27, 2026, 9:15 AM EDT
Price at Filing:
$15.05
Real-time Price:
$16.19
Change:
+$1.14 (+8%)
Market Cap:
$3.562B
RLAY
Apr 27, 2026, 6:00 AM EDT
Price at Filing:
$15.21
Real-time Price:
$16.19
Change:
+$0.9848 (+6%)
Market Cap:
$3.562B
RLAY
Apr 16, 2026, 4:05 PM EDT
Price at Filing:
$16.11
Real-time Price:
$16.19
Change:
+$0.0848 (+0.53%)
Market Cap:
$3.562B
RLAY
Mar 16, 2026, 8:30 AM EDT
Price at Filing:
$10.80
Real-time Price:
$16.19
Change:
+$5.39 (+50%)
Market Cap:
$3.562B
RLAY
Feb 26, 2026, 4:16 PM EST
Price at Filing:
$9.46
Real-time Price:
$16.19
Change:
+$6.73 (+71%)
Market Cap:
$3.562B
RLAY
Feb 26, 2026, 4:10 PM EST
Price at Filing:
$9.16
Real-time Price:
$16.19
Change:
+$7.03 (+77%)
Market Cap:
$3.562B
RLAY
Feb 03, 2026, 7:10 AM EST
Price at Filing:
$8.27
Real-time Price:
$16.19
Change:
+$7.92 (+96%)
Market Cap:
$3.562B